STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] PRO DEX INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRO DEX INC (PDEX)11/21/2025. The filing shows the director acquired 900 shares of common stock at a price of $32.73 per share in a directly owned account, bringing the directly held total to 2,900 shares. On the same date, an additional 2,200 shares of common stock were acquired at $32.70 per share and are reported as indirectly owned by the director’s spouse, bringing the spouse’s reported indirect holdings to 16,896 shares. The filing is signed by an attorney-in-fact on behalf of the reporting person.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Philp Katrina Marie Kramer

(Last) (First) (Middle)
C/O 2361 MCGAW AVENUE

(Street)
IRVINE CA 92614

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRO DEX INC [ PDEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/21/2025 A 900 A $32.73 2,900 D
Common Stock 11/21/2025 A 2,200 A $32.7 16,896 I By Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Alisha Charlton, as attorney-in-fact for Katrina Marie Kramer Philp 11/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filing disclose for PRO DEX INC (PDEX)?

The Form 4 reports that a director of PRO DEX INC acquired additional common stock on 11/21/2025, both directly and indirectly through a spouse.

How many PDEX shares did the director buy directly on 11/21/2025?

The director acquired 900 shares of PRO DEX INC common stock at $32.73 per share, increasing directly owned holdings to 2,900 shares.

How many PRO DEX INC (PDEX) shares were acquired indirectly by the director’s spouse?

The filing shows an indirect acquisition of 2,200 shares of PRO DEX INC common stock at $32.70 per share, reported as held by spouse, for total indirect holdings of 16,896 shares.

What is the reporting person’s relationship to PRO DEX INC (PDEX)?

The reporting person is identified as a Director of PRO DEX INC.

Does the Form 4 for PDEX involve any derivative securities?

No derivative securities are reported; Table II for derivative securities is present but contains no transactions.

Who signed the Form 4 for PRO DEX INC (PDEX)?

The form was signed by /s/ Alisha Charlton, as attorney-in-fact for Katrina Marie Kramer Philp on 11/24/2025.
Pro-Dex Inc Colo

NASDAQ:PDEX

PDEX Rankings

PDEX Latest News

PDEX Latest SEC Filings

PDEX Stock Data

106.54M
2.09M
35.94%
32.91%
7.98%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
IRVINE